| Literature DB >> 34458652 |
Marian A Ackun-Farmmer1,2, Clyde T Overby1,2, Brittany E Haws3, Regine Choe1,4, Danielle S W Benoit1,2,3,5,6.
Abstract
Despite widespread use of conventional diagnostic methods in orthopaedic applications, limitations still exist in detection and diagnosing many pathologies especially at early stages when intervention is most critical. The use of biomaterials to develop diagnostics and theranostics, including nanoparticles and scaffolds for systemic or local applications, has significant promise to address these shortcomings and enable successful clinical translation. These developments in both modular and holistic design of diagnostic and theranostic biomaterials may improve patient treatments for myriad orthopaedic applications ranging from cancer to fractures to infection.Entities:
Year: 2021 PMID: 34458652 PMCID: PMC8386480 DOI: 10.1016/j.cobme.2021.100308
Source DB: PubMed Journal: Curr Opin Biomed Eng ISSN: 2468-4511